Table 1.
Baseline Characteristics of Patients with Intravitreal Injection of Bevacizumab
| Characteristics | Study patients (n=17) |
|---|---|
| Number of patients | 17 |
| Gender | |
| Male | 7 |
| Female | 10 |
| Number of eyes | 20 |
| Right eye | 9 |
| Left eye | 11 |
| Age of onset (mean±SD) | 54.9±9.1 |
| Range | 44–81 |
| Type of DM (n) | |
| Type 1 insulin-dependent diabetes mellitus (IDDM) | 3 |
| Type 2 non-insulin-dependent diabetes mellitus (NIDDM) | 14 |
| Duration of DM (years) (mean±SD) | 15.1±8.6 |
| Hemoglobin A1c (mean±SD) | 9.5±2.1 |
| Presence of hypertension [n (%)] | 8 (47) |
| Prior PRP [n (%)] | 5 (29) |
SD, standard deviation; DM, diabetes mellitus; PRP, panretinal laser photocoagulation.